Body response analytics, lLc
About us
Body Response Analytics
Our PGx business offers the ultimate combination of cutting-edge technology and expert interpretation, providing personalized and accurate results for better health outcomes. Experience the difference with our commitment to excellence and individualized care.
Reduce the costly and lengthy trial and error approach to finding your correct medication
Professional team
Dr. Chris Trujillo, PharmD
Founder/CEO of Body Response Analytics, LLC
My journey in the field of pharmacogenomics began with my experience in public health overdose prevention. As a licensed pharmacist, I saw the devastating impact that opioid overdoses were having on communities, and I was determined to do something about it.
Through my work, I became aware of the critical role that genetics can play in an individual's response to medication, including their risk of overdose. I was fascinated by the potential of pharmacogenomics to not only reduce the risk of overdose, but also to improve overall health outcomes by tailoring treatment plans to each individual's unique needs.
This realization led me to pursue further education and training in pharmacogenomics, and I am now deeply committed to using this knowledge to make a difference in people's lives. I believe that by using genetic information to guide medical decisions, we can help healthcare providers choose the right drug and dose for each patient, reducing the risk of adverse reactions and improving treatment outcomes.